MedTrace Logo

Psychosocial Correlates of Trait Emotional Intelligence and Psychosomatic Symptoms Among Adolescents Exposed to Bullying and the Effects of Mindfulness-Based Stress Reduction.

NCT07694908 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-07-14

No results posted yet for this study

Summary

This study examines the psychosocial correlates of trait emotional intelligence and psychosomatic symptoms among adolescents exposed to bullying and analyzes the effetiveness of Mindfulness Based Stress Reduction (MBSR) program through a randomized controlled trial.

The study is two phased, in which the Phase 1 includes a cross sectional correlational survey that was administered to 403 adolescents aged 14 to 18 years studying in secondary schools and colleges of Rawalpindi and Islamabad, Pakistan to analyze the relationships among childhood traumatic experiences, mindfulness, and level of bullying exposure with trait emotional intelligence and psychosomatic symptoms to identify eligible participants for Phase 2.

In Phase 2, about 44 adolescents meeting eligibility criteria were randomly assigned to either an intervention group that received the 8 week MBSR intervention (n=22) or waitlist control group (n=22). Pre and post assessments were done to examine changes in trait emotional intelligence and psychosomatic symptoms, following the mbsr intervention.

Conditions

  • Childhood Trauma
  • Stress
  • Emotional Intelligence
  • Psychosomatic Disorders
  • Mindfulness
  • Adolescent Mental Health
  • Post Traumatic Stress
  • Bullying Victimisation

Interventions

BEHAVIORAL

Mindfulness Based Stress Reduction (MBSR)

8 week structured online group program based on the Kabat-Zinn 1990 protocol adapted for adolescents delivered via video conferencing in weekly 90 minute sessions comprising mindfulness meditation breathing exercises body scan Mindful movement and group Discussions to increase present moment awareness reduce stress reactivity improve Emotional stability.

Sponsors & Collaborators

  • Fatima Jinnah Women University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07694908 on ClinicalTrials.gov